Lionshead Wealth Management, LLC

Position in MRK — Merck & Co., Inc.

CIK 2056752 New York, NY

Position in MRK

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$739,389

+$52,534 QoQ

Shares Held

5,754

+0.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.31%

of 13F equity value

Holder Rank

#2,368

of 3,769 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Lionshead Wealth Management, LLC holds $4,038,187 across 5 Drug Manufacturers - General names. MRK ranks #3 (18.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	4,720	$1,187,740
2	LLY	ELI LILLY & Co	969	$1,162,247
3	MRK	Merck & Co., Inc. This page	5,754	$739,389
4	PFE	Pfizer Inc	29,172	$702,461
5	JNJ	Johnson & Johnson	970	$246,350

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$739,389	5,754	+0.8%	Shares	Sole	2026-07-28
2026-03-31	$686,855	5,710	+0.1%	Shares	Sole	2026-05-11
2025-12-31	$600,403	5,704	+1.7%	Shares	Sole	2026-01-13
2025-09-30	$470,931	5,611	+0.1%	Shares	Sole	2025-10-10
2025-06-30	$443,533	5,603	-1.5%	Shares	Sole	2025-08-12
2025-03-31	$510,375	5,686	+6.4%	Shares	Sole	2025-05-14
2024-12-31	$531,422	5,342	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.